Jiangsu Bioperfectus Technologies Co

Jiangsu Bioperfectus Technologies Co Inventory

The Inventory of Jiangsu Bioperfectus Technologies Co (688399.SS) as of Nov 5, 2026 is 51.50 M CNY. In the previous year, Inventory was 67.04 M CNY — a change of -23.18% (lower).

Inventory

51.50 MCNY

YoY

-23.18%

Last updated:

Inventory of Jiangsu Bioperfectus Technologies Co is 2025 51.50 M CNY. Inventory of Jiangsu Bioperfectus Technologies Co was 2024 67.04 M CNY. It decreases by -23.18% lower compared to the previous year.

The Jiangsu Bioperfectus Technologies Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
14.02 M CNY
Jan 1, 2019
18.98 M CNY
Jan 1, 2020
162.86 M CNY
Jan 1, 2021
250.35 M CNY
Jan 1, 2022
236.26 M CNY
Jan 1, 2023
93.86 M CNY
Jan 1, 2024
67.04 M CNY
Jan 1, 2025
51.50 M CNY
The Jiangsu Bioperfectus Technologies Co Inventory history
YEARInventoryYoY
51.50 MCNY-23.18%
67.04 MCNY-28.57%
93.86 MCNY-60.27%
236.26 MCNY-5.63%
250.35 MCNY+53.72%
162.86 MCNY+758.12%
18.98 MCNY+35.36%
14.02 MCNY-21.83%
17.94 MCNY+16.41%
15.41 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jiangsu Bioperfectus Technologies Co Stock analysis

What does Jiangsu Bioperfectus Technologies Co do? Jiangsu Bioperfectus Technologies Co., Ltd. generates revenue through the research, development, production, and sale of in vitro diagnostic reagents and supporting testing instruments. The company's primary products include in vitro diagnostic reagents, supporting testing instruments, and in vitro testing services, which are utilized in infectious disease prevention and control, clinical testing, large-scale population screening, and prenatal and postnatal care management. Domestic and overseas markets represent the main sales channels for these products, with the firm targeting healthcare providers and laboratories that require diagnostic solutions for disease detection and patient care. The company's focus on in vitro diagnostic reagents and supporting instruments positions it within the healthcare sector, serving customers who need reliable testing tools for clinical and public health applications. By offering comprehensive diagnostic solutions, Jiangsu Bioperfectus addresses the needs of medical institutions and public health initiatives, particularly in areas such as infectious disease management and maternal care. The firm's product portfolio supports both routine clinical testing and specialized population screening programs. Jiangsu Bioperfectus Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jiangsu Bioperfectus Technologies Co stock

Inventory of Jiangsu Bioperfectus Technologies Co is 51.50 M CNY in 2025.

Inventory of Jiangsu Bioperfectus Technologies Co changed from 67.04 M CNY to 51.50 M CNY, representing a -23.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Jiangsu Bioperfectus Technologies Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Jiangsu Bioperfectus Technologies Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jiangsu Bioperfectus Technologies Co

All Key Metrics — Jiangsu Bioperfectus Technologies Co